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Abstract
The birth of new genes is an important motor of evolutionary innovation. Whereas many new
genes arise by gene duplication, others originate at genomic regions that do not contain any
gene or gene copy. Some of these newly expressed genes may acquire coding or non-coding
functions  and  be  preserved  by  natural  selection.   However,  it  is  yet  unclear  which  is  the
prevalence  and underlying  mechanisms of  de novo gene  emergence.  In  order  to  obtain  a
comprehensive  view  of  this  process  we  have  performed  in-depth  sequencing  of  the
transcriptomes of  four mammalian species,  human, chimpanzee, macaque and mouse, and
subsequently  compared the assembled transcripts  and the corresponding syntenic  genomic
regions.  This  has  resulted  in  the  identification  of  over  five  thousand  new  transcriptional
multiexonic events in human and/or chimpanzee that are not observed in the rest of species. By
comparative genomics we show that the expression of these transcripts is associated with the
gain of regulatory motifs upstream of the transcription start site (TSS) and of U1 snRNP sites
downstream of the TSS. We also find that the coding potential of the new genes is higher than
expected by chance, consistent with the presence of protein-coding genes in the dataset. Using
available human tissue proteomics and ribosome profiling data we identify several  de novo
genes with translation evidence. These genes show significant purifying selection signatures,
indicating that they are probably functional. Taken together, the data supports a model in which
frequently-occurring new transcriptional events in the genome provide the raw material for the
evolution of new proteins.  
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 Author summary
The presence in every genome of a set  of genes which are unique to the species,  lacking
homologues in other species, has puzzled scientists for the past 20 years. How have these
genes originated? The advent of massively parallel RNA sequencing (RNA-Seq) has provided
new clues,  with  the  discovery  of  an  unsuspectedly  high  number  of  transcripts  that  do  not
correspond  to  typical  protein-coding  genes  and  which  could  serve  as  a  substrate  for  this
process. Here we have examined RNA-Seq data from several mammalian species in order to
define a set of putative newborn genes in human and chimpanzee and investigate what drives
their expression. This is the largest-scale project that tries to address this question. We have
found thousands of transcripts that are human- and/or chimpanzee-specific and which are likely
to have originated  de novo from previously non-transcribed regions of the genome. We have
observed an enrichment in transcription factor binding sites in the promoter regions of these
genes when compared to other species, consistent with the idea that the gain of new regulatory
motifs results in de novo gene expression. We also show that some of the genes encode new
functional  proteins  expressed  in  brain  or  testis,  which  may have  contributed  to  phenotypic
novelties in human evolution. 
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INTRODUCTION
New genes continuously arise in genomes. Evolutionary 'inventions' include small proteins that
have functions related to the adaptation to the environment, such as antimicrobial peptides or
antifreeze proteins, which have independently evolved in different groups of organisms  [1,2].
Whereas many genes arise by gene duplication [3], other evolve de novo from previously non-
genic regions in the genome  [4–10]. These genes are only detected in one or a few related
species  [4,5,11].  Syntenic  genomic  regions  from more  distant  species  do  not  express  any
similar genes. In de novo gene evolution the full sequence space can be potentially explored for
new adaptive functions, without the limitations imposed by high similarity to an already existing
gene [12]. In Drosophila, recently emerged genes are often essential [13,14], highlighting their
functional importance. 
Recent efforts to characterize  de novo originated genes in humans and other primates have
focused on annotated protein-coding genes [5,15–17]. For example Chen and colleagues have
identified 64 human protein-coding genes that correspond to putative long non-coding RNAs
(lncRNAs) in macaque and proposed that these human proteins have originated from previously
existing non-coding transcripts [17]. Other studies have focused on specific genes. One case is
the hominoid-specific antisense gene NCYM, which is over-expressed in neuroblastoma  [18].
This gene inhibits the activity of glycogen synthase kinase 3β (GSK3β), which targets NMYC for
degradation. Another example is FLJ33706, which encodes a 194 amino acid protein expressed
in different human brain structures  [19]. This type of genes, sometimes called orphans, have
been described in a wide range of organisms, including yeast  [20,21],  mouse  [22],  rat  [23],
insects [24–26] and plants [27,28]. They share common features, such as short protein size and
tissue-specific expression [6,29].
Massively  parallel  RNA sequencing  (RNA-Seq)  has  revealed  that  a  large  fraction  of  the
genome, extending far beyond the set of annotated genes, is transcribed [30,31] and possibly
translated [32–36]. Many genes that are annotated as lncRNAs are lineage-specific and display
high transcriptional  turnover  [37,38].  These observations have important  implications for  de
novo gene evolution, as it means that there is abundant raw material for the evolution of new
functional proteins. 
Here  we use transcriptomics  data  from four  mammalian  species to  quantify  the amount  of
transcription  that  is  human-  and/or  chimpanzee-specific  and  investigate  the  molecular
mechanisms driving the expression of these genes. The majority of  de novo genes originate
from regions with conserved genomic synteny in macaque. Analysis of these regions reveals
that the expression of the gene is associated with the gain of novel regulatory motifs in the
promoter region and U1snRNP splice sites downstream of the transcription start site. We also
show that at least a subset of the newly evolved genes are likely to encode functional proteins.
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RESULTS
Assembly of annotated and novel transcripts from strand-specific RNA-Seq data
We used strand-specific sequencing of polyadenylated RNA (polyA+ RNA-Seq) from several
tissues from human, chimpanzee, macaque and mouse, to perform de novo transcript assembly
with Cufflinks [39]. The total number of RNA-Seq datasets was 43, of which 26 were generated
in this study and the rest were public datasets from previous studies  [37,40,41]. The set of
tissues sampled included testis and brain, previously noted to be enriched in  de novo genes
[16,40]. In this study, we will refer to gene as the set of transcripts merged into a single loci by
Cufflinks.  Any  genome  unmapped  reads  were  assembled  with  Trinity  for  the  sake  of
completeness [42]. 
Subsequently we selected transcripts with a size longer than 300 nucleotides (nt). This removed
any sequencing products resulting from one single amplified paired end read (2x100 nt).  We
also filtered out  all  those genes having a  per-base read coverage lower than 5,  to  ensure
transcript  completeness  (see  Materials  and  Methods). A negative  control  lacking  reverse
transcriptase in the library construction step (RT-) indicated that the probability of a transcript to
represent DNA contamination was very low, virtually 0 in the case of multiexonic transcripts.  To
ensure a highly robust set of transcripts we filtered out intronless genes. This also removed
possible promotor- or enhancer-associated transcripts (PROMPTS and eRNAs). As a result of
this process, we recovered 99,670 human, 102,262 chimpanzee, 93,860 macaque and 85,688
mouse transcripts merged in 34,188 human, 35,915 chimpanzee, 34,427 macaque and 31,043
mouse gene loci. This included a high fraction of the long multiexonic genes annotated in each
species plus a significant number of additional non-annotated genes (Figure 1A). The number of
non-annotated genes was much larger in chimpanzee and macaque than in human and mouse,
mostly  due  to  the  inclusion  of  many  lncRNAs  in  the  human  and  mouse  annotations.  Not
surprisingly, novel genes tended to be shorter and expressed at lower levels than annotated
genes (Figures 1B and 1C). In humans, annotated genes represented about 98% (testis) and
99-99.5% (rest of tissues) of the transcriptional cost as measured in terms of sequencing reads. 
Identification of de novo human and chimpanzee genes
Next, we used BLAST-based sequence similarity searches [43] to identify the subset of de novo
genes that could have originated in human, chimpanzee, or the common ancestor of these two
species since the divergence from macaque (hominoid-specific genes).  These genes survived
an exhaustive search for homologues in related species, including the transcript assemblies
described above, the transcript assemblies we obtained using a similar procedure but using
previously published non-stranded single read RNA-Seq data for nine vertebrate species [44],
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Ensembl gene annotations for the same set of species, and the complete expressed sequence
tag (EST) and non-redundant (nr) protein databases from NCBI. We also employed genomic
alignments to discard any transcripts expressed in syntenic regions in other species that could
have been missed by BLAST  (S1 Fig).  This pipeline resulted in 634 human-specific  genes
(1,029  transcripts),  780  chimpanzee-specific  genes (1,307  transcripts)  and  1,300  hominoid-
specific genes (3,062 transcripts). By adding these numbers the total number of candidate de
novo genes was 2,714 (5,398 transcripts) (Figure 2A).
As we used strand-specific RNA sequencing we could unambiguously identify a large number of
antisense transcripts. Many of them were located within intronic regions (38.31%) and others
partially overlapped exonic regions from other genes (10.62%). The rest of de novo transcripts
were  located  in  ntergenic  regions  (51.07%).  These  percentages  were  similar  for  human-,
chimpanzee- and hominoid-specific genes (Figure 2B). Eight de novo genes matched annotated
protein-coding genes  (S1 Table). One example was the gene  GTSCR1 (Gilles de la Tourette
syndrome chromosome region, candidate 1), encoding a 137 amino acid long protein and with
proteomics evidence for 23.53% of the sequence. Curiously, the human protein-coding genes,
including  GTSCR1,  were  annotated  as  long  non-coding  RNAs  (lncRNAs)  in  a  subsequent
Ensembl version (77). About 20% of de novo genes matched annotated lncRNAs or sequence
entries in the 'EST' or 'nr' databases. The identification of lncRNAs in the set was not surprising
as  it  has  been  previously  reported  that  they  tend  to  show  low  phylogenetic  conservation
[37,38,45]. The majority of de novo genes were novel genes (~ 80%, Figure 2C). 
Transcripts from  de novo genes were shorter and expressed at lower levels than those from
conserved annotated genes (S2 Fig). These biases have also been noted in young annotated
primate protein-coding genes  [5,40]. In general,  de novo genes were located in regions  with
conserved synteny in macaque (> 75%, S3 Fig). The proportion of  de novo transcripts with
complete synteny was similar to the one observed for conserved transcripts. De novo transcripts
were enriched in transposable elements, about 20% of their total transcript length was covered
by  transposable elements  compared  to  only  about  8%  for  conserved  genes  (S4  Fig).  An
enrichment in transposable elements was previously observed in primate-specific protein-coding
genes [5] and in lncRNAs in general [46].
De novo genes are enriched in testis
We determined the number of human and chimpanzee genes expressed in different tissues
using the RNA-Seq data. The vast majority of  de novo transcripts were expressed in testis
(93.8-94.5%),  as  were  transcripts  that  showed  higher  conservation  levels  (Figure  2D).  In
contrast, in brain, liver and heart, de novo transcripts were underrepresented when compared to
other transcripts. The gene expression enrichment in testis resembles the bias observed for
mammalian lncRNAs [41,47,48]. The high number of  de novo genes detected in testis did not
appear to be the result of increased capacity to detect weakly expressed genes in this tissue as
5
deduced from the overall  distribution of  gene expression values (S5 Fig).  It  was previously
reported that young human protein-coding genes were enriched in the brain [16], but we did not
detect a similar bias in our data.
As a result of the expression tissue differences mentioned earlier, de novo genes were twice as
likely  to show testis restricted expression as the rest  of  genes (94.1%-96.4% in contrast  to
~64% of all assembled transcripts, see Material and Methods). The use of gene expression data
from GTEx, although restricted to human annotated transcripts, produced consistent results (S6
Fig). The majority of de novo genes were detected in all or nearly all the 60 individuals tested for
testis in GTEx  [49],  indicating that they are expressed in a stable manner in the population
(Figure 2E).
Signatures of transcription initiation and elongation in de novo genes
Divergent  transcription  from  bidirectional  promoters  is  widespread  in  eukaryotic  genomes
[50,51] and leads to the expression of numerous antisense transcripts, most of them poorly
conserved in other species and generally lacking coding potential  [52]. It has been proposed
that the reuse of existing promoters can be a driving force of new gene origination  [53]. We
searched for bidirectional  promoters by scanning the genome for  transcription start  sites of
antisense transcripts at a distance < 1 Kb. Positive cases showed a typical separation between
the two TSSs of about 100 bp, consistent with the presence of a bidirectional promoter (S7 Fig)
However, de novo genes were not enriched in bidirectional promoters with respect to the rest of
genes (20% versus 29.81%), indicating that this is probably not the predominant mechanism for
the formation of de novo genes.
Comparison of GC content in the region surrounding the TSSs clearly revealed that  de novo
genes  are  more  A/T-rich  than  conserved  annotated  genes  (S8  Fig).  We  searched  for
overrepresented transcription factor binding sites in the promoters of de novo genes using the
programs PEAKS [54] and HOMER [55] (Figure 3A and 3B). With PEAKS we identified a strong
enrichment of sites for CREBP, RFX, and JUN  in the first 100 bp upstream of the TSS (p-value
< 10-5, motif frequency > 20% higher than in other regions). Whereas CREBP (cAMP-responsive
element  binding  protein)  and  JUN  (transcription  factor  AP1)  are  general  activators,  RFX
(regulatory factor X) has been associated with expression in testis [56,57]. With HOMER  we
identified two novel motifs (M1, M2) also enriched in the first 100 bp upstream of the TSS (p-
value < 10-5, motif frequency > 20% higher than in other regions). M1 and M2 matched the
transcription factor TFIIB (RNA polymerase II complex) downstream element (BREd), which has
the consensus sequence G/A-T-T/G/A-T/G-G/T-T/G-T/G [58].
We argued that, if the expression of de novo human and chimpanzee genes was at least partly
due to the co-option of genomic sequences as active promoters, we should observe a lower
frequency  of  the  relevant  TFBS in  the  corresponding  syntenic  regions in  macaque.  This  is
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exactly what we found for the five motifs mentioned earlier, whereas not differences existed for
conserved genes (Figure 3C, S9 Fig). This was consistent with the gain of new transcription
factor binding sites in the hominoid branches after the split from macaque. We also noted that
the occurrence of transposable elements (Figure 3D) tended to decrease near the TSS of all
gene classes except  for  endogenous retrovirus-derived long terminal  repeats (LTRs),  which
overlap 13% of the proximal promoters of de novo genes compared to 5% of conserved genes.
Further analyses indicated that LTRs tend to contribute CREB motifs (Figure 3E). 
Transcription  elongation  is  highly  dependent  on  the  presence  of  U1  small  nuclear
ribonucleoprotein recognition sites downstream of the TSS, whereas poly(A) sites (PAS) cause
transcription  termination  [59].  As  in  standard  multiexonic  mRNAs,  de  novo genes  showed
enrichment of U1 sites and depletion of PAS downstream of the TSS. As U1 sites suppress the
effect of PAS sites, we predicted that, if transcription elongation is restricted to hominoids, we
should see an underrepresentation of U1 sites in the corresponding macaque syntenic regions,
but not necessarily of PAS sites. We indeed observed this pattern in de novo genes, whereas
no differences were detected for conserved genes (Figure 3F). This is consistent with the idea
that the gain of U1 sites contributes to the stabilization of de novo genes.
De novo originated proteins
Most de novo genes were not annotated in the databases and their coding status was unclear.
We analyzed two coding properties in  de novo genes: ORF length and ORF score. The latter
score was based on hexanucleotide frequencies in  bona fide sets of coding and non-coding
sequences (See Methods, [36]).  The median length of the longest ORF in de novo genes was
52 amino acids, shorter than for proteins encoded by annotated coding RNAs (codRNA) with
the same transcript length distribution as de novo genes and comparable to ORFs from similarly
sampled intronic sequences (Figures 4A and 4B). In contrast, the coding score of the longest
ORF was higher in  de novo genes than in intronic ORFs (Wilcoxon test, p-value < 10 -10) and
comparable to the one for proteins shorter than 100 amino acids in the set of annotated protein-
coding genes. Therefore, the results are consistent with an scenario in which a large fraction of
de novo genes encode short proteins. 
Next  we  searched for  experimental  evidence  of  proteins  produced by  de novo genes.  We
employed mass-spectrometry data from a recent study [60], limiting the searches to the same
tissues used here for transcript assembly to increase specificity (testis, brain, heart and liver),
and also searched in Proteomics DB [61]. We identified uniquely mapping peptides in 6 de novo
genes, comprising 1 human- and 5 hominoid-specific genes (Table 1, Figure 4E). All of them
were expressed in testis, and one of them was preferentially expressed in heart. In addition, we
detected signatures of translation in 5 human- and 10 hominoid-specific  de novo genes using
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available ribosome profiling sequencing data from human brain [62]. Overall 22 de novo genes,
comprising 31 different transcripts, had evidence of translation. 
Closer inspection of the genes with protein evidence showed that their size (median 76 amino
acids) and coding potential (median 0.0414) were in line with values observed in de novo genes
in general (Figures 4C and 4D). Two thirds of the ORFs were truncated in the syntenic region in
macaque and none of them were detected in the syntenic region in mouse, consistent with a
recent origination (S10 Fig). These genes also showed signatures of purifying selection (Table
2). This was assessed by calculating the fraction of  nucleotide differences in different  gene
regions (introns, exons, ORF) with respect to the corresponding macaque syntenic genomic
sequences. Sequences under selective constraints will  have a lower number of substitutions
than sequences evolving in a neutral manner. This is a conservative test, because selection is
not expected to have acted in the macaque branch in de novo genes and positive selection may
increase  the  number  of  substitutions.  Despite  this,  we  found  that  signatures  of  purifying
selection could be clearly distinguished in ORFs with evidence of translation when compared to
intronic regions, as it occurs in standard conserved coding sequences (Fisher-test, p-value < 10-
5, Table 2). However, in general, the longest ORF in de novo genes did not show a significant
decrease in the rate of divergence with respect to macaque, suggesting that the majority of
these ORFs do not correspond to functional proteins or that positive selection is blurring the
signal.
DISCUSSION
Here we performed a large-scale transcriptomics-based investigation of the emergence of new
genes in hominoids.  Our strategy was annotation-independent, which allowed us to recover
many novel, non-annotated genes, and compare species for which the level of annotation varies
greatly. The approach was entirely different from that employed in previous studies in which the
initial  datasets  were  composed  of  annotated  protein  coding  genes  in  humans  that  lacked
homologous proteins in other species [5,17,40,63]. We instead focused on new transcriptional
events and subsequently analysed the coding potential of the transcripts. Therefore, the genes
identified  here  are  a  more  recent  subset  of  transcriptional  active  loci  or  genes than  those
obtained previously.
We employed a polyadenylated RNA sequencing strategy that was based on a combination of
high sequencing depth (average of 115 Million mapped reads per sample) and strand-specific
sequencing. This, together with our annotation-blind strategy, resulted in the identification of
2,714 putative  de novo genes expressing  5,398 transcripts, which is more than one order of
magnitude the number found in previous studies [5,17,40,63]. The set of genes was obtained
using a carefully chosen per base read coverage threshold, which allowed the full recovery of
complete  sequences  while  permitting  the  detection  of  transcripts  expressed  at  low  levels.
Whereas our analysis was based on multiexonic genes we have to consider that many recently
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evolved genes may not have yet  acquired the capacity to be spliced, as shown by several
examples in Drosophila [7]. Therefore, there are probably many more de novo genes that those
covered here. We found that de novo genes constituted about 4% of all expressed multiexonic
genes in human and chimpanzee. Although this seems a very high fraction, it is consistent with
previous transcriptomics-based studies in insects  [64,65]. As these genes tended to be short
and expressed at low levels, their associated transcriptional cost is relatively small. We showed
that de novo human/hominoid genes show characteristic promoter and splicing signals and are
expressed in a consistent manner across individuals.
The proportion of de novo genes with conserved genomic synteny in macaque was comparable
to  the  proportion  of  conserved  genes.  Given  the  low  number  of  nucleotide  differences  in
neutrally evolving regions between the two species (~ 6%), we could reliably used syntenic
alignments to  examine transcription-related  sequence  features.  We found an enrichment  of
transcription factor binding sites and U1snRNP motifs in the human and chimpanzee genes with
respect to the corresponding genomic regions in macaque, consistent with the idea that the gain
of regulatory motifs underlies  de novo gene origination. This scenario had been proposed for
the the formation of  a new gene in mouse  [66,67] but  had not  been tested until  now at  a
genome-wide scale. Interestingly, in addition to general activators and polymerase II complex
sites, we found an enrichment in RFX motifs. Although there are several members of the family
that bind to similar sequences, many of the sites are probably recognized by RFX2, which is
highly expressed in testis and has been involved in spermiogenesis [57]. 
Different studies dating the age of genes have found an excess of genes of very recent origin
when  compared  to  older  gene  classes  [65,64].  This  suggests  that  many  young  genes are
subsequently lost, which is consistent with the relatively constant number of genes observed in
a taxon. We found that genes with evidence of translation had significant signatures of purifying
selection, indicating that at least some of them are functional. However, the signature was very
weak for de novo genes in general, which would be consistent with a scenario in which many of
these  genes  are  dispensable.  In  contrast,  studies  in  Drosophila  indicate  that  directional
selection determines the fate of  de novo genes from the very early stages  [7]. Although we
focused on possible coding functions, some of these genes may have non-coding functions.
This is specially relevant in the case of antisense transcripts which can potentially influence the
expression of the transcript in the opposite orientation [68]. It is important to consider that the
annotations alone may not suffice to differentiate between coding and non-coding transcripts as
many annotated lncRNAs may translate short  peptides according to ribosome profiling data
[33,35,69].  The  coding  score  of  de  novo genes  was  clearly  non-random.  One  possible
explanation is that natural selection rapidly eliminate transcripts that produce toxic peptides [70],
as one can expect such peptides to often have unusual amino acid compositions. 
Here we detected 20 putative new human proteins using ribosome profiling from brain  [71].
Considering that the expression of most  de novo genes was restricted to testis, for which no
ribosome profling data has yet been published, we expect this number to increase substantially
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in the future. Mass-spectrometry has important limitations for the detection of short peptides
[72].,  but  we  could  nevertheless  detect  8  putative  proteins,  mostly  from testis.  Our  results
indicate  that  expression of  new loci  in  the genome takes place at  a  very high rate  and is
probably mediated by random mutations that generate new active promoters. The new genes
form the substrate for the evolution of new functions and species-specific adaptations.
MATERIALS AND METHODS
Ethics statement
Chimpanzee and macaque samples were obtained from the Primate Bio-Bank of the Biomedical
Primate  Research  Center  (BPRC).  BPRC  offers  state-of-the-art  animal  facilities  (AAALAC
accredited) and is fully compliant with regulations on the use of non-human primates for medical
research.  BPRC's  Primate Tissue Bank is  one of  the biggest  non-human primate  banks in
Europe and it is involved in the framework of the EuprimNet Bio-Bank (www.euprim-net.eu). The
EUPRIM-Net Bio-Bank is conducted and supervised by the scientific government board along
all lines of EU regulations and in harmonisation with Directive 2010/63/EU on the Protection of
Animals Used for Scientific Purposes. The animals used for tissue collection in all cases are
diagnosed with  cause  of  death  other  than  their  participation  in  this  study  and  without  any
relation to the tissues used.
Library preparation and strand-specific polyA+ RNA-Seq protocol
Human and mouse total RNA was purchased from Amsbio. Chimpanzee and macaque total
RNA was extracted using a miRNeasy Mini kit from tissue samples obtained at the Biomedical
Primate Research Centre (BPRC, Netherlands). Mouse samples were from a pool of 3 males
and 3 females (Balb/C strain). 
Libraries were prepared using the TruSeq Stranded mRNA Sample Prep Kit v2 according to the
manufacturer’s  protocol.  PolyA+  RNA was  purified  from  250-500  mg  of  total  RNA using
streptavidin-coated magnetic beads (AMPure XP) and subsequently fragmented to ~300 bp.
cDNA was  synthesized  using  reverse  transcriptase  (SuperScript  II,  Invitrogen)  and  random
primers. We did not add reverse transcriptase to one of the human testis replicate samples to
use it as a control of DNA contamination (RT-). The strand-specific RNA-Seq library preparation
was based on the incorporation of dUTP in place of dTTP in the second strand of the cDNA.
Double-stranded DNA was further used for library preparation. Such dsDNA was subjected to A-
tailing and ligation of the barcoded Truseq adapters. Library amplification was performed by
PCR on the size selected fragments using the primer cocktail supplied in the kit. Sequencing
was done with a Illumina HiSeq 2000 sequencer in a paired-end design (2x100 nt) according to
the manufacturer’s instructions. Library preparation and sequencing were done at the Genomics
Unit of the Center for Regulatory Genomics (CRG, Barcelona, Spain). 
10
RNA-Seq datasets
The  polyA+ RNA-Seq  included  96  sequencing  datasets  for  9  different  species:  43  strand-
specific paired end data (~3 billion reads) and 53 single read data (~3.2 billion reads). The
strand-specific  data  was  employed  for  the  assembly  of  reference  transcripts  for  human,
chimpanzee, macaque and mouse (Fig. 1 for a summary of results). For comparative purposes,
we used the same tissues and number of biological samples for human and chimpanzee (liver,
heart,  brain  and testis;  two  biological  replicates  per  tissue).  For  macaque and  mouse,  the
outgroup  species,  we  added  available  strand-specific  RNA-Seq  data  from  other  tissues:
adipose, skeletal muscle for macaque [40], ovary and placenta for mouse  [41,47]. The single
read  data  corresponded  to  5  primate  species  (human,  chimpanzee,  gorilla,  orangutan,
macaque) and 4 additional vertebrates (mouse, chicken, platypus and opossum) in 6 different
tissues (brain, cerebellum, heart, kidney, liver and testis) [44]. Although these experiments were
based on single reads and had lower coverage than the strand-specific RNA-Seq data, they
were useful  to increase the number of species with expression data for sequence similarity
searches. More information about the samples can be found in supplementary file 2.
Read mapping and transcriptome assembly
RNA-Seq  sequencing  reads  underwent  quality  filtering  using  Condetri  (v.2.2)  [73] with  the
following  settings  (-hq=30 –lq=10).  Adapters  were  trimmed from filtered  reads  if  at  least  5
nucleotides of the adaptor sequence matched the end of each read. In all experiments, reads
below 50 nucleotides or with only one member of the pair were not considered. We retrieved
genome sequences and gene annotations from Ensembl v. 75 [74]. We aligned the reads to the
correspondent reference species genome with Tophat (v. 2.0.8) [75] with parameters –N 3, -a 5
and –m 1, and including the correspondent parameters for paired-end and strand-specific reads
whenever necessary. Multiple mapping to several locations in the genome was allowed unless
otherwise stated. 
We performed gene and transcript  assembly with Cufflinks (v 2.2.0)  [76] for each individual
sample. Per-base read coverage and FPKM (fragments per kilobase of transcript per million
mapped  fragments)  values  were  calculated  for  each  transcript  and  gene  as  described  by
Trapnell  et  al.  (2010).  We  only  considered  assembled  transcripts  that  met  the  following
requirements: a) the transcript was covered by at least 4 reads, b) Abundance was higher than
1% of the most abundant isoform of the gene and, c) <20% of reads were mapped to multiple
locations in the genome. 
Subsequently, we used Cuffmerge [76] to build a single set of assembled transcripts per each
species, separately for the strand-specific and the single read based RNA-Seq experiments. We
compared our set of assembled transcripts with gene annotation files from Ensembl (gtf format,
v.75)  with  Cuffcompare  [76] to  identify  transcripts  corresponding  to  annotated  genes.  This
included the categories '=' (complete match), 'c' (contained), 'j' (novel isoform), “e” and “o” (other
exonic  overlaps  in  the  same  strand).  Genes  for  which  none  of  the  assembled  transcripts
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matched  an  annotated  gene  were  labeled  novel.  In  human,  82%  and  44.5%  of  the  total
annotated  protein-coding  and  non-coding  genes  (lincRNA,  antisense  and  processed
transcripts), respectively, were recovered. 
Additionally, we run Trinity  [42], which reconstructs transcripts in the absence of a reference
genome,  with all  unmapped reads in  each species (read length >= 75 nucleotides).  Before
running Trinity, unmapped reads were normalized by median using Khmer (parameters –C 20,
-k 20, -N 4). This allowed the recovery of any transcripts falling into non-assembled parts of the
genome. We selected transcripts with a minimum size of 300 nucleotides.
We obtained a set of reference transcripts from the strand-specific RNA-Seq data using a per-
nucleotide  read  coverage  >=  5.  This  choice  was  based  on  the  relationship  between  read
coverage and percentage of fully reconstructed annotated coding regions (CDS, longest one per
gene) for the subset of genes mapping to annotated protein coding genes (Ensembl v.75), using
only the categories '=' and 'c' in Cuffcompare (18,694 protein-coding genes). For values higher
than 5 there was no substantial increase in the number of fully reconstructed CDS (coverage >=
5: 87.8%; coverage >= 10: 88.5%; coverage >= 20: 89.4%). The selection was based on coding
regions and not complete transcripts because of the known existence of alternative transcription
start sites in many annotated transcripts causing uncertainty in the latter parameter  [77]. Very
similar results were obtained for CDS shorter  than 500 nucleotides or genes with only one
annotated  CDS,  indicating  that  protein  length  or  gene  complexity  has  little  effect  on  the
suitability of this threshold.
Transcript assembly with the RT- control (see above) resulted in 22,803 different sequences that
presumably corresponded to genomic DNA contamination, resulting from regions resistant to
DNAse treatment. Except for the reverse transcriptase, all other reagents were added in the
same concentration as in the other samples. Therefore, the number of contaminant fragments
must be considered an upper boundary, as in a normal RNA-Seq experiment these fragments
are probably sequenced much less efficiency as they have to compete with the genuine RT
products.  The  sequences  obtained  in  the  RT-  control  did  not  contain  any  introns  and  the
majority of them were shorter than 300 nucleotides (98.58%). 
Genomic comparisons
Reference transcripts  were classified into  three categories depending on their  location with
respect to transcripts from other genes: a) Intergenic: Transcripts that did not overlap any other
assembled loci. b) Overlappping Intronic: Transcripts located within introns of other assembled
genes  in  the  opposite  strand.  c)  Overlapping  antisense:  Transcripts  partially  or  completely
overlapping exons from other assembled genes in the opposite strand. 
We downloaded long interspersed element (LINE), short interspersed element (SINE) and long
terminal repeat (LTR) annotations in the human and chimpanzee genomes from RepeatMasker
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(same genome versions than in Ensembl v.75)  [78]. We used BEDTools  [79] to identify any
overlap between transcripts and/or genomic elements. 
We downloaded pairwise syntenic genomic alignments of human against chimpanzee, macaque
and mouse; and of chimpanzee against human, macaque and mouse, aligned by the blastz
alignment  [80],  from  UCSC.  We  developed  an  in-house  Python  script  to  recover  syntenic
regions corresponding to a given human or chimpanzee transcript or to regions upstream and
downstream of a human or chimpanzee transcription start site (TSS). 
We  scanned  the  human  and  chimpanzee  genomes  to  identify  transcripts  with  bidirectional
promoters. We recovered any antisense pairs in which the distance between the two TSSs was
< 1 kb). For annotated genes in general the frequency was 29.81%, compared to 20% for  de
novo genes. This was significantly higher than that expected by chance (Binomial Test, p-value
<< 10-5, 20% versus 5.31%).
Identification of de novo genes
We developed a pipeline to identify de novo genes in human and chimpanzee based on the lack
of homologues in other species. We first selected multiexonic transcripts from the reference
transcriptome assemblies. Then, we performed exhaustive sequence similarity searches against
sequences from other species with the BLAST suite of programs and, subsequently, searched
for overlapping transcripts in genomic syntenic regions.
Sequence similarity searches, using reference human or chimpanzee transcripts as query, were
performed against  the complete transcriptome assemblies from the nine different  vertebrate
species,  gene annotations from Ensembl v.75 for the same species and the EST and non-
redundant  protein  “nr”  [81] NCBI  databases.  We  employed  both  BLASTN  and  TBLASTX
programs [43], with an E-value threshold of 10-4. All BLAST searches were performed with the
filter of low-complexity regions activated and so we discarded any transcripts in which self-hits
were not reported. Species-specific genes were those for which no transcripts (or transcripts
from any paralogs) had sequence similarity hits to transcripts in any other species. We identified
634  human-specific  genes  (1,029  transcripts)  and  780  chimpanzee-specific  genes  (1,307
transcripts). In the case of hominoid-specific genes we allowed for hits to gorilla and orangutan
in  addition  to  human and  chimpanzee.  The  pipeline  yielded  1,300  hominoid-specific  genes
(3,062 transcripts). About one third of them (221 genes and 1,016 transcripts) were reference
transcripts in both species (multiexonic, coverage >=  5) and the rest were identified via the
complete transcriptome assemblies, EST and/or nr databases. Because not all of them were
detected as reference transcripts  in both species the number of  hominoid-specific  genes is
different for human and chimpanzee (604 and 916, respectively). 
For  synteny-based identificaton  of  homologues we took  advantage  of  the  existing  pairwise
syntenic  genomic  alignments  from  UCSC.  We  employed  data  from  human,  chimpanzee,
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macaque  and  mouse.  If  two  transcripts  overlapped  (>=  1bp)  in  the  syntenic  region  we
considered it as evidence of homology. We reclassified the de novo genes accordingly.
Tissue gene expression
We analyzed the patterns of tissue expression in assembled transcripts, considering a transcript
as  expressed  in  one  tissue  if  FPKM  >  0.  We  measured  the  number  of  tissue-restricted
transcripts using a previously proposed metric [82]:
τ=
∑
i=n
i=1
(1−xi)
N−1
Where N is the number of tissues and x i is the FPKM expression value of the transcript in the
sample normalized by the maximum expression value over all tissues. We classified cases with
a τ > 0.85 as preferentially expressed in one tissue or tissue-restricted.
For  de novo genes annotated in Ensembl v.75 we obtained expression data from the GTEx
project,  which  comprises  a  large  number  of  human  tissue  samples.  We  used  this  data  to
calculate the number of genes showing tissue-restricted expression as well as the number of
testis samples with detectable expression of a given gene. 
Motif analysis
We searched for significantly overrepresented motifs in  de novo and conserved genes using
computational approaches. We employed sequences spanning from 300 bp upstream to 300 bp
downstream  of  the  transcription  start  site  (TSS).   Redundant  TSS  positions  were  only
considered once. With PEAKS [54] we identified three TRANSFAC motifs  [83] enriched in  de
novo genes,  corresponding  to  CREB,  JUN,  RFX (p-value  <  10-5  and minimum of  30  motif
occurrences). With HOMER [55] we identified  two novel motifs (M1, M2) enriched in de novo
genes in the first 100 bp upstream of the TSS (p-value < 10 -5 and enrichment > 20% when
compared  to  other  regions).  M1  and  M2  matched  the  transcription  factor  TFIIB  (RNA
polymerase II complex) downstream element (BREd), which has the consensus sequence G/A-
T-T/G/A-T/G-G/T-T/G-T/G [58]. 
For graphical representation of the results, we computed the relative motif density in 100 bp
windows  upstream  and  downstream  of  the  TSS  in  human  and  chimpanzee,  and  the
corresponding genomic syntenic regions in macaque and mouse. We used MEME [84] to scan
the sequences for the occurrence of motifs (matches to weight matrices with a p-value < 10 -5).
The average number of motif occurrences (motif density) was normalized to values between 0
and 1, where 1 corresponded to the highest density of a given motif in a sequence window.
It has been previously proposed that new genes tend to gain new U1 sites and lose PAS sites
as they become more mature  [85]. We used MEME with the same parameters as described
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above to search for U1 (U1 snRNP 5’ splice site consensus motif) and PAS (poly-adenylation
signals) sites 500 bp sequences upstream and downstream of the TSS (see Sampledata.xlsx
for weight matrices). PAS motifs found < 500bp downstream of a U1 site were not considered
since the PAS effect is abolished by snRNPs bound to these U1 motifs at such distances. 
Coding score
We defined an open reading frame (ORF) in a transcript as any sequence starting with an ATG
codon and finishing at a stop codon (TAA, TAG or TGA). In addition we require it to be at least
75 nucleotides long (24 amino acids), which is the the size of the smallest complete human
polypeptide found in genetic screen studies [86]. 
In each ORF we computed a coding score based on hexamer frequencies in bona fide coding
and non-coding  sequences  [36].  Specifically,  we  first  computed one coding score (CS)  per
nucleotide hexamer:
CShexamer(i)=log (
freqcoding(hexamer (i))
freqnon−coding(hexamer (i))
)
The  coding  hexamer  frequencies  were  obtained  from  all  human  transcripts  encoding
experimentally validated proteins. The non-coding hexamer frequencies were calculated using
the longest ORF in intronic regions, which were selected randomly from expressed protein-
coding genes.  The hexamer  frequencies were computed separately  for  ORFs with  different
lengths to account for any possible length-related biases (24-39, 40-59, >60 amino acids). Next,
we used the following statistic to measure the coding score of an ORF: 
CSORF=
∑
i=n
i=1
CShexamer(i )
n
where i is each sequence hexamer in the ORF, and n the number of hexamers considered.
The  hexamers  were  calculated  in  steps  of  3  nucleotides  in  frame  (dicodons).  We  did  not
consider the initial hexamers containing a Methionine or the last hexamers containing a STOP
codon. Given that all ORFs were at least 75 nucleotides long the minimum value for n was 22.
In coding RNAs (CodRNA all) the annotated ORF was selected for further analysis. In addition,
to account for possible due to biases in transcript length, we randomly selected a subset of
protein-coding transcripts  with  the same transcript  length distribution as transcripts  from  de
novo genes (CodRNA short).  In sequences with no annotated coding sequence (introns and
transcripts  from  de novo genes),  we chose the longest  ORF considering all  three possible
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frames. The only exception was when the longest ORF in another frame had a higher coding
score than expected for non-coding sequences (0.0448 if ORF < 40 aa; 0.0314 if 60 aa > length
ORF >= 40 aa; 0.0346 if length ORF >= 60 aa; p-value < 0.05) or it was longer than expected
for non-coding sequences (>= 134 aa, p-value < 0.05), in which case we selected this other
ORF (in 3.4% of the cases). 
Ribosome profiling data
We downloaded data from ribosome profiling experiments in human brain tissue [62]. Ribosome
profiling reads were filtered as described previously [36]. We then used Bowtie2 [87] to map the
reads to the human assembled transcripts with no mismatches. We considered each strand
independently since the RNA-Seq data was strand-specific.  RNA-Seq reads from the same
experiment were also mapped to  de novo transcripts to determine how many of them were
expressed (FPKM > 0). Because of the low detectability of ribosome association at low FPKM
expression values [36], two ribosome profiling reads mapping to a predicted ORF were deemed
sufficient for the signal to be reported. 
Mass spectrometry data 
We used available mass-spectrometry data from human frontal cortex, liver, heart and testis
[60,61] to identify any putative peptides produced by de novo genes. Mass-spectrometry data
was searched using the Proteome Discoverer software v.1.4.1.14 (Thermo Fisher Scientific,
United States) using MASCOT v2.5  [88] as search engine. The database used contained the
human entries in SwissProt [89], the most common contaminants and putative peptides derived
from the translation of transcripts from de novo genes. Carbamidomethylation for cysteines was
set as fixed modification whereas acetylation in protein N-terminal and oxidation of methionine
were set as variable modifications. Peptide tolerance was 7 ppm in MS and 20mmu in MS/MS
mode,  maximum number  of  missed cleavages was set  at  3.  The Percolator  [90] algorithm
implemented in the Proteome Discoverer software was used to estimate the qvalue and only
peptides with qvalue < 0.01 and rank = 1 were considered as positive identifications. Lastly, we
only considered unique peptides matching to young transcripts by using BLAST with short query
parameters  to  search  the  candidate  peptides  against  all  predicted  ORFs  in  assembled
transcripts. Additionally, we searched for evidences of peptides assigned to our set of de novo
annotated genes in Proteomics DB [61]. We found 6 de novo genes with proteomics evidence,
two of them were annotated in Ensembl as lncRNAs and expressed in ≥55 testis samples from
GTEx. Details of the results can be found in  supplementary file 2. 
Statistical data analyses and plots
The analysis of the data, including generation of plots and statistical test, was done using R
[91].
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SUPPORTING INFORMATION
Supplementary file 1 contains the supplementary tables and figures (Table S1 and Figures S1-
S10). Supplementary file 2 contains information of the RNA-Seq datasets, proteomics hits and
motif  weight  matrices.  Annotation  files  of  de  novo genes  identified  here  are  available  at
evolutionarygenomics.imim.es  (Publications,  Datasets,  ptr_denovo.gtf  for  chimpanzee  gene
coordinates and hsa_denovo.gtf for human gene coordinates). 
FIGURE LEGENDS
Figure 1. Global properties of assembled transcriptomes. a) Percentage of annotated and
novel genes and transcripts using strand-specific deep polyA+ RNA sequencing. Classification
is based on the comparison to reference gene annotations in Ensembl v.75. 70.65 and 87.77%
of annotated genes in human and mouse are classified as protein-coding. Detailed statistics on
the  total  and  per-tissue  number  of  assembled  genes  and  transcripts  is  available  in  the
supplementary  material.  b)  Cumulative  density  of  nucleotide length in  annotated and  novel
assembled  transcripts.  c)  Cumulative  density  of  expression  values  in  logarithmic  scale  in
annotated and novel assembled transcripts. Expression is measured in fragments per kilobase
per million mapped reads (FPKM) values, selecting the maximum value across all samples.
Figure 2. Identification and characterization of de novo genes in human and chimpanzee.
a) Simplified phylogenetic tree indicating the nine species considered in this study. In all species
we had RNA-Seq data from several tissues. Chimpanzee, human, macaque and mouse were
the species for which we performed strand-specific deep polyA+ RNA sequencing. We indicate
the branches in which  de novo genes were defined, together with the number of genes.  b)
Categories of transcripts in de novo genes based on genomic locations. Intergenic, transcripts
that are not overlapping any other gene; Overlapping antisense, transcripts that overlap exons
from other genes in the opposite strand; Overlapping intronic, transcripts that overlap introns
from other genes in the opposite strand, with no exonic overlap.  c)  Classification of  de novo
genes based on existing evidence in databases. Annotated; genes classified as annotated in
Ensembl v.75; EST/nr; non-annotated genes with BLAST hits (10-4) to expressed sequence tags
(EST) and/or non-redundant protein (nr) sequences in the same species. Novel; rest of genes.
d) Patterns of gene expression in four tissues. Brain refers to frontal cortex. Transcripts with
FPKM > 0 in a tissue are considered as expressed in that tissue.  In red boxes,  fraction of
transcripts  whose  expression  is  restricted  to  that  tissue  (t  >  0.85,  see  Methods).  Chimp
conserved, transcripts assembled in chimpanzee not classified as de novo. Human conserved,
transcripts assembled in human not classified as de novo.  e) Number of testis GTEx samples
with expression of  de novo and conserved genes. We considered all  annotated genes with
FPKM > 0 in at  least  one testis sample.  Conserved, genes sampled from the total  pool of
annotated genes analyzed in GTEx with the same distribution of FPKM values than in annotated
de novo genes (n=200).
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Figure  3.  Recent  signatures  of  transcription  in  de  novo genes.  a)  Overrepresented
transcription factor binding sites (TFBS) in the region -100 to 0 with respect to the transcription
start site (TSS) in de novo genes. The region from -300 to +300 with respect to the TSS was
analysed (n=3,875). Color code relates to normalized values (highest value is yellow). b) Fine-
grained motif density 200bp upstream of the TSS is shown. c) Comparison of motif density in
genomic  syntenic  regions  in  macaque  for  de  novo transcripts  (n=3,116)  and  conserved
transcripts  (n=4,323,  randomly  taken  human  and  chimpanzee  annotated  transcripts  not
classified as  de novo).  Significant differences between human/chimpanzee and macaque are
indicated; Fisher-test; *, p-value < 0.05; **, p-value < 0.01. c) Comparison of motif density in
promoters with and without long terminal repeat (LTR) in the region -500 to 0 with respect to the
TSS. Significant differences in motif density in the -100 bp window are indicated. d) Density of
the main human transposable elements (TE) families around the TSS of de novo and conserved
transcripts. Regions -3 kB to +3 kB with respect to the TSS were analysed. LTR frequency is
higher in the region -100 to +100 in de novo genes when compared to conserved genes (Fisher-
test p-value < 10-18). e) Signatures of transcription elongation in de novo and conserved genes.
Density of  U1 and PAS motifs  in  the 500bp region upstream and downstream of  the TSS.
Comparison of U1 and PAS motif density in genomic syntenic regions in macaque for de novo
transcripts (n=3,116) and conserved transcripts (n=4,323). There is an increase of U1 motifs in
de novo transcripts when compared to macaque (indicated by a black arrow, Fisher-test,  p-
value=0.016 for the region +100 to +200).
Figure 4. Coding potential of de novo genes. a-d) ORF length and coding score for ORFs in
different  sequence  types.  De  novo gene,  longest  ORF  in  de  novo transcripts  (n=1,933).
CodRNA (all),  annotated coding  sequences from Ensembl  v.75  (n=8,462).  CodRNA (short),
annotated coding sequences sampled as to have the same transcript length distribution as de
novo transcripts  (n=1,952). Intron, longest ORF in intronic sequences from annotated genes
sampled  as  to  have  the  same  transcript  length  distribution  as novo transcripts  (n=5,000);
Proteogenomics – ORFs in  de novo transcripts with peptide evidence by mass-spectrometry;
Ribosome profiling – ORFs in de novo transcripts with ribosome association evidence in brain.
e)  Example  of  hominoid-specific  de  novo gene  with  evidence  of  protein  expression  from
proteogenomics, with RNA-Seq read profiles in two human samples. (f) Example of hominoid-
specific  de novo gene with RNA-Seq and ribosome profiling read profiles.  Predicted coding
sequences  are  highlighted  with  red  boxes  and  the  putative  encoded  protein  sequences
displayed. 
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Table 1
Detection Technique Assembly
gene ID
Assembly
transcript ID
Agec Tissued Protein
length
Annotatione
Proteogenomicsa
XLOC_175402 hsa_00362506 Hominoid Heart 36
LncRNA
(ENSG00000223485)
XLOC_068697 hsa_00142705 Hominoid Testis 37 Novel
XLOC_085716 hsa_00181285 Hominoid Testis 64 Novel
XLOC_088783 hsa_00187116,
hsa_00187117,
hsa_00187118
Hominoid Testis 148, 136,
61
LncRNA
(ENSG00000263417)
XLOC_105288 hsa_00223807 Hominoid Testis 199 Novel
XLOC_196865 hsa_00404039 Human Testis 49 Novel
Ribosome profilingb XLOC_002919 hsa_00006742,
hsa_00006743,
hsa_00006744
Hominoid Brain, Heart 68, 64, 58 Novel
XLOC_031861 hsa_00068400 Human Brain 58 LncRNA
(ENSG00000273409)
XLOC_042102 hsa_00090118 Hominoid Brain 90 LncRNA
(ENSG00000257061)
XLOC_050821 hsa_00107269 Human Brain 56 Novel
XLOC_057303 hsa_00119633 Hominoid Testis, Brain 52 Novel
XLOC_073846 hsa_00154236 Hominoid Brain 54 Novel
XLOC_082421 hsa_00173626,
hsa_00173627
Hominoid All 4 tissues 95, 95 LncRNA
(ENSG00000265666)
XLOC_085590 hsa_00181107,
hsa_00181108
Hominoid Brain,Testis 89, 83 Novel
XLOC_104066 hsa_00221170 Hominoid Brain 68 Novel
XLOC_106910 hsa_00227119 Human Brain 36 LncRNA
(ENSG00000228999)
XLOC_152506 hsa_00317537 Hominoid Brain 53 LncRNA
(ENSG00000251423)
XLOC_160844 hsa_00333276,
hsa_00333277
Hominoid Brain 65, 65 Novel
XLOC_168602 hsa_00348960 Hominoid Brain 29 LncRNA
(ENSG00000228408)
XLOC_184660 hsa_00380291 Human Brain 101 LncRNA
(ENSG00000236197)
XLOC_195038 hsa_00400469 Human Brain 42 novel
Table 1. Human de novo genes with evidence of protein translation.  a  Proteogenomics, detection is based on the
identification of mass spectrometry peptides with a unique match to an ORF and corrected p-value (q-value) < 0.01
(brain, heart, liver and testis data from Kim et al., 2014).  b  Ribosome profiling, detection is based on the presence of
23
ribosome profiling reads overlapping the ORF (brain data from Gónzalez et al., 2014). cAge refers to whether the gene
is human-specific or hominoid-specific.  dThe tissue with preferential expression is indicated, using the RNA-Seq data
generated here for human brain, heart, liver and testis. eAnnotation refers to the classification of the transcripts as novel
or annotated in Ensembl v.75.
Table 2
Transcript Intronsc
Dataset
Complete
exons
ORFb Rest exonic
sequence
1. Species-specific de novo transcripts 58.74 *** 61.92 57.75 61.47
2. Hominoid-specific de novo transcripts 59.11 ***  60.76 58.67 60.42
3. De novo transcripts with protein evidence 48.71 *** 43.51 ** 49.91 59.65
4. Conserved transcripts 43.85 *** 29.39 *** 62.47 60.14
Table 2. Divergence with macaque in different gene regions. Number of nucleotides differences per Kb in macaque
syntenic regions with respect to human or chimpanzee sequences. Protein evidence is from proteomics or ribosome
profiling (Table 1). We did not consider regions with gaps or transcripts with partial synteny. bORF: refers to the longest
ORF in transcripts from  de novo genes, or with protein evidence/annotated in the rest.   cIntrons:  sampled intronic
regions of  size  500 pb from the  same set  of  transcripts.  Conserved:  conserved human protein  coding transcripts
annotated in Ensembl v.75. We tested for differences between complete exons and introns, and ORF and introns with
the Fisher test: *p-value < 0.05, **p-value<0.005, ***p-value < 10-5. 
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